Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Investing.com Canada, BioSpace, Targeted Oncology and FirstWord Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 24d ago.
Quick answers
Why is "Tango reports 82% tumor response rate in trial of combo therapy for advanced pan" trending?
Because 7 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Tango Therapeutics stock falls despite positive cancer trial data Yahoo Finance · 24d ago
- Form 8K Tango Therapeutics Inc For: 23 October By Investing.com Investing.com India · 24d ago
- Form 8K Tango Therapeutics Inc For: 23 October By Investing.com Investing.com Canada · 24d ago
- ESMO 2026: Tango trips on sinking response rates in pancreatic cancer but will move to Phase 3 BioSpace · 24d ago
- Vopimetostat Plus Daraxonrasib Yields 82% ORR in MTAP-Deleted PDAC Targeted Oncology · 24d ago
- ESMO26: Tango's updated pancreatic cancer data gets chilly market reception FirstWord Pharma · 24d ago
- How Tango Improved On Revolution's 'Unprecedented' Results Investor's Business Daily · 24d ago
- Tango builds on Revolution Medicines’ pancreatic cancer success STAT · 24d ago
- Tango combo clears Rasonque bar, Takeda’s Innovent bet gets early returns, plus more from #ESMO26 Endpoints News · 24d ago
- Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer STAT · 24d ago
Topics
Related trends
2 satellites just burned up in Earth's atmosphere
Two ESA Cluster satellites have completed their final reentry into Earth's atmosphere, marking the end of a 26-year scientific mission.
Lionel Messi set for 'Last Tango' with Argentina as Cristiano Ronaldo pouts on Portugal sidelines
3 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.